Thomas K. Equels - Apr 21, 2025 Form 4 Insider Report for AIM ImmunoTech Inc. (AIM)

Role
CEO & President, Director
Signature
/s/ Thomas K Equels
Stock symbol
AIM
Transactions as of
Apr 21, 2025
Transactions value $
$50,000
Form type
4
Date filed
4/23/2025, 04:35 PM
Previous filing
Apr 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AIM Common Stock Purchase $50K +1.97M +103.66% $0.03 3.87M Apr 11, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025.